Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study

被引:22
|
作者
Aly, Mai M. [1 ]
Meshref, Taghreed S. [2 ]
Abdelhameid, Marwa A. [3 ]
Ahmed, Shimaa A. [4 ]
Shaltout, Asmaa S. [5 ]
Abdel-Monienn, Alaa Eldin [2 ]
Hamad, Dina A. [2 ]
机构
[1] Assiut Univ, Fac Med, Dept Internal Med, Clin Hematol Unit, Assiut, Egypt
[2] Assiut Univ, Fac Med, Dept Internal Med, Crit Care Unit, Assiut, Egypt
[3] Aswan Univ, Fac Med, Dept Internal Med, Aswan, Egypt
[4] Qena Univ, Fac Med, Dept Internal Med, Qena, Egypt
[5] Assiut Univ, Fac Med, Dept Med Microbiol & Immunol, Assiut, Egypt
来源
JOURNAL OF BLOOD MEDICINE | 2021年 / 12卷
关键词
COVID-19; NLR; d-NLR; LMR; PLR; Egypt; PARAMETERS;
D O I
10.2147/JBM.S316681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Purpose: Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. Methods: A retrospective study on 496 COVID-19 Egyptian patients, managed in four tertiary centers, grouped into non-severe, severe, and critical. Patients' laboratory assessment including total leucocyte count (TLC), absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC), NLR, d-NLR, LMR and, PLR were reported as well as C reactive protein (CRP), D-dimer and serum ferritin. Results: TLC, ANC, AMC, NLR, d-NLR and, PLR were highest in the critical group (p<0.001 for all except AMC p=0.033), while this group had the least ALC and LMR (p=0.049 and <0.001, respectively). Higher CRP and d-dimer levels were reported in the critical group (p<0.001). At the same time, higher ferritin was found in the severe group more than the critical and non-severe groups (p<0.001, p=0.005, respectively). We calculated the optimal cut-off values of the hematological ratio; NLR (3.5), d-NLR (2.86), PLR (192), and LMR (3). D-NLR had the highest specificity (89.19%), while NLR had the highest sensitivity (71.38%). By univariate logistic regression, age, DM, HTN, cardiovascular diseases, COPD, NLR, d-NLR, LMR and PLR, CRP, steroid, oxygen aids, and mechanical ventilation were associated with the severity of COVID-19. Still, only age, NLR, CRP, and oxygen aid were independent predictors in multivariate logistic regression. Conclusion: NLR is a predictor for severity in COVID-19. LMR, d-NLR, and PLR may assist in risk stratification.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 50 条
  • [1] LSC-2021-Can Hematological Ratios Predict Outcome of COVID-19 Patients? Egyptian Multicentric Study
    Mai, Aly
    Meshref, Taghreed S.
    Abdelhameid, Marwa A.
    Ahmed, Shimaa A.
    Shaltout, Asmaa S.
    Abdel-Moniem, Alaa Eldin
    Hamad, Dina A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] The outcome of COVID-19 in patients with hematological malignancy
    Yigenoglu, Tugce N.
    Ata, Naim
    Altuntas, Fevzi
    Basci, Semih
    Dal, Mehmet Sinan
    Korkmaz, Serdal
    Namdaroglu, Sinem
    Basturk, Abdulkadir
    Hacibekiroglu, Tuba
    Dogu, Mehmet H.
    Dal, Kursat
    Erkurt, Mehmet A.
    Turgut, Burhan
    Ulgu, Mustafa Mahir
    Celik, Osman
    Imrat, Ersan
    Birinci, Suayip
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1099 - 1104
  • [3] The outcome of COVID-19 in patients with hematological malignancy
    Tiglioglu, Pinar
    Albayrak, Murat
    Tiglioglu, Mesut
    Ozturk, Hacer Berna Afacan
    Aras, Merih Reis
    Saglam, Bugra
    Maral, Senem
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (01) : 83 - 89
  • [4] The outcome of COVID-19 in patients with hematological malignancy
    Pınar Tığlıoğlu
    Murat Albayrak
    Mesut Tığlıoğlu
    Hacer Berna Afacan Öztürk
    Merih Reis Aras
    Buğra Sağlam
    Senem Maral
    [J]. memo - Magazine of European Medical Oncology, 2022, 15 : 83 - 89
  • [5] The outcome of COVID-19 in patients with hematological malignancy
    Yigenoglu, Tugce N.
    Basci, Semih
    Dal, Mehmet S.
    Korkmaz, Serdal
    Turgut, Burhan
    Altuntas, Fevzi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1255 - 1255
  • [6] Changes in the hematological cells ratios are associated with death in COVID-19 patients
    Perez, I. A. Gutierrez
    Perez-Rubio, G.
    Buendia-Roldan, I.
    Hernandez-Zenteno, R.
    Chavez-Galan, L.
    Falfan-Valencia, R.
    Guzman-Guzman, I. P.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Risk factors and outcome of COVID-19 in patients with hematological malignancies
    Pinana, Jose Luis
    Martino, Rodrigo
    Garcia-Garcia, Irene
    Parody, Rocio
    Morales, Maria Dolores
    Benzo, Gonzalo
    Gomez-Catalan, Irene
    Coll, Rosa
    De la Fuente, Ignacio
    Luna, Alejandro
    Merchan, Beatriz
    Chinea, Anabelle
    de Miguel, Dunia
    Serrano, Ana
    Perez, Carmen
    Diaz, Carola
    Lopez, Jose Luis
    Saez, Adolfo Jesus
    Bailen, Rebeca
    Zudaire, Teresa
    Martinez, Diana
    Jurado, Manuel
    Calbacho, Maria
    Vazquez, Lourdes
    Garcia-Cadenas, Irene
    Fox, Laura
    Pimentel, Ana I.
    Bautista, Guiomar
    Nieto, Agustin
    Fernandez, Pascual
    Vallejo, Juan Carlos
    Solano, Carlos
    Valero, Marta
    Espigado, Ildefonso
    Saldana, Raquel
    Sisinni, Luisa
    Ribera, Josep Maria
    Jimenez, Maria Jose
    Trabazo, Maria
    Gonzalez-Vicent, Marta
    Fernandez, Noemi
    Talarn, Carme
    Montoya, Maria Carmen
    Cedillo, Angel
    Sureda, Anna
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
  • [8] Risk factors and outcome of COVID-19 in patients with hematological malignancies
    José Luis Piñana
    Rodrigo Martino
    Irene García-García
    Rocío Parody
    María Dolores Morales
    Gonzalo Benzo
    Irene Gómez-Catalan
    Rosa Coll
    Ignacio De La Fuente
    Alejandro Luna
    Beatriz Merchán
    Anabelle Chinea
    Dunia de Miguel
    Ana Serrano
    Carmen Pérez
    Carola Diaz
    José Luis Lopez
    Adolfo Jesús Saez
    Rebeca Bailen
    Teresa Zudaire
    Diana Martínez
    Manuel Jurado
    María Calbacho
    Lourdes Vázquez
    Irene Garcia-Cadenas
    Laura Fox
    Ana I. Pimentel
    Guiomar Bautista
    Agustin Nieto
    Pascual Fernandez
    Juan Carlos Vallejo
    Carlos Solano
    Marta Valero
    Ildefonso Espigado
    Raquel Saldaña
    Luisa Sisinni
    Josep Maria Ribera
    Maria Jose Jimenez
    Maria Trabazo
    Marta Gonzalez-Vicent
    Noemí Fernández
    Carme Talarn
    Maria Carmen Montoya
    Angel Cedillo
    Anna Sureda
    [J]. Experimental Hematology & Oncology, 9
  • [9] Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients
    Kumar, Yogesh
    Kumari, Amita
    Kumar, Tribhuwan
    Jha, Kamlesh
    Zabihullah, Md.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [10] Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study
    Lamure, Sylvain
    Dulery, Remy
    Di Blasi, Roberta
    Chauchet, Adrien
    Laureana, Cecile
    Deau-Fischer, Benedicte
    Drenou, Bernard
    Soussain, Carole
    Rossi, Cedric
    Noel, Nicolas
    Choquet, Sylvain
    Bologna, Serge
    Joly, Bertrand
    Kohn, Milena
    Malak, Sandra
    Fouquet, Guillemette
    Daguindau, Etienne
    Bernard, Sophie
    Thieblemont, Catherine
    Cartron, Guillaume
    Lacombe, Karine
    Besson, Caroline
    [J]. ECLINICALMEDICINE, 2020, 27